Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease

Abstract

Intravitreal ranibizumab combined with other ablative therapies as an initial treatment is an effective and safe treatment approach for Coats' disease that may improve the visual acuity and reduce the subretinal fluid, exudates and telangiectasia.